Brian Armstrong

And the name of it is?

And the name of it is?

New Limits.

New Limits.

Yes.

Yes.

New Limits.

New Limits.

So they've been incredible progress.

So they've been incredible progress.

Yeah.

Yeah.

Well, biotech does move more slowly, but it's moved faster than I would have thought.

Well, biotech does move more slowly, but it's moved faster than I would have thought.

I thought this was going to be like five years of just basic research.

I thought this was going to be like five years of just basic research.

But it turned out actually within the first two or three years, they were able to successfully demonstrate reprogramming of human cells to store function they had when they were younger.

But it turned out actually within the first two or three years, they were able to successfully demonstrate reprogramming of human cells to store function they had when they were younger.

And the first drug candidate is probably going to go into clinical trials next year.

And the first drug candidate is probably going to go into clinical trials next year.